These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 14575984)

  • 1. Breast cancer and hormone-replacement therapy: the Million Women Study.
    Bliss JM; Gray R
    Lancet; 2003 Oct; 362(9392):1328-9; author reply 1330-1. PubMed ID: 14575984
    [No Abstract]   [Full Text] [Related]  

  • 2. Breast cancer and hormone-replacement therapy: the Million Women Study.
    Yong SP
    Lancet; 2003 Oct; 362(9392):1331; author reply 1332. PubMed ID: 14575992
    [No Abstract]   [Full Text] [Related]  

  • 3. The influence of time from menopause and mammography on hormone therapy-related breast cancer risk assessment.
    Chlebowski RT; Anderson GL
    J Natl Cancer Inst; 2011 Feb; 103(4):284-5. PubMed ID: 21278357
    [No Abstract]   [Full Text] [Related]  

  • 4. Estrogen therapy and breast cancer.
    Gambrell RD
    Int J Fertil; 1990; 35(4):202-4. PubMed ID: 1977710
    [No Abstract]   [Full Text] [Related]  

  • 5. Breast cancer and hormone-replacement therapy: the Million Women Study.
    Van Leeuwen FE; Rookus MA
    Lancet; 2003 Oct; 362(9392):1330; author reply 1330-1. PubMed ID: 14575989
    [No Abstract]   [Full Text] [Related]  

  • 6. Timing of hormone therapy influences breast cancer risk.
    Harv Womens Health Watch; 2011 Apr; 18(8):7. PubMed ID: 21544975
    [No Abstract]   [Full Text] [Related]  

  • 7. Postmenopausal hormone therapy and the risk of breast cancer. A clinician's view.
    Speroff L
    Maturitas; 2004 Sep; 49(1):51-7. PubMed ID: 15351096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer and hormone-replacement therapy: the Million Women Study.
    Garton M
    Lancet; 2003 Oct; 362(9392):1328; author reply 1330-1. PubMed ID: 14575985
    [No Abstract]   [Full Text] [Related]  

  • 9. Hormone replacement therapy, breast and endometrial cancer.
    La Vecchia C
    Eur J Cancer Prev; 1996 Oct; 5(5):414-6. PubMed ID: 8972283
    [No Abstract]   [Full Text] [Related]  

  • 10. Hormone therapy and breast cancer risk: trumping fear with facts.
    Kaunitz AM
    Menopause; 2006; 13(2):160-3. PubMed ID: 16645526
    [No Abstract]   [Full Text] [Related]  

  • 11. Risk factors for in situ breast cancer.
    Longnecker MP; Bernstein L; Paganini-Hill A; Enger SM; Ross RK
    Cancer Epidemiol Biomarkers Prev; 1996 Dec; 5(12):961-5. PubMed ID: 8959317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Does menopausal hormonal replacement therapy increase the risk of breast cancer?].
    Punnonen R
    Duodecim; 1996; 112(12):1110-5. PubMed ID: 10593013
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased risk of recurrence after hormone replacement therapy in breast cancer survivors.
    Holmberg L; Iversen OE; Rudenstam CM; Hammar M; Kumpulainen E; Jaskiewicz J; Jassem J; Dobaczewska D; Fjosne HE; Peralta O; Arriagada R; Holmqvist M; Maenpaa J;
    J Natl Cancer Inst; 2008 Apr; 100(7):475-82. PubMed ID: 18364505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer decline mirrors fall in hormone use, spurs both debate and research.
    McNeil C
    J Natl Cancer Inst; 2007 Feb; 99(4):266-7. PubMed ID: 17312300
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of HRT and the subsequent risk of cancer.
    Beral V; Banks E; Reeves G; Appleby P
    J Epidemiol Biostat; 1999; 4(3):191-210; discussion 210-5. PubMed ID: 10695959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. More controversy over breast cancer rates in the USA.
    Brown S
    Menopause Int; 2007 Jun; 13(2):51-2. PubMed ID: 17802647
    [No Abstract]   [Full Text] [Related]  

  • 17. [Alarming data on the risk of breast cancer following estrogen replacement therapy should be interpreted carefully].
    Odlind V
    Lakartidningen; 2005 Apr 18-24; 102(16):1217-8. PubMed ID: 15921094
    [No Abstract]   [Full Text] [Related]  

  • 18. Breast cancer incidence and use of hormone therapy in Denmark 1978-2007.
    von Euler-Chelpin M
    Cancer Causes Control; 2011 Feb; 22(2):181-7. PubMed ID: 21103920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Menopausal hormone therapy in BRCA1 mutation carriers: uncertainty and caution.
    Chlebowski RT; Prentice RL
    J Natl Cancer Inst; 2008 Oct; 100(19):1341-3. PubMed ID: 18812547
    [No Abstract]   [Full Text] [Related]  

  • 20. Breast cancer risk: is postmenopausal hormone therapy ever safe?
    Ganz PA
    Menopause; 2005; 12(6):653-5. PubMed ID: 16278604
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.